FDA advisory committee considers Pfizer's COVID-19 vaccine for children ages 5 to 11

A Food and Drug Administration advisory committee is meeting Tuesday to consider endorsing Pfizer's COVID-19 vaccine for children ages 5 to 11. Dr. Mark Kline, chief physician at New Orleans Children's Hospital, spoke with CBSN's Tanya Rivero about what's next.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting